PE20060768A1 - Composicion farmaceutica que comprende hidroclorotiazida y telmisartano - Google Patents
Composicion farmaceutica que comprende hidroclorotiazida y telmisartanoInfo
- Publication number
- PE20060768A1 PE20060768A1 PE2005001465A PE2005001465A PE20060768A1 PE 20060768 A1 PE20060768 A1 PE 20060768A1 PE 2005001465 A PE2005001465 A PE 2005001465A PE 2005001465 A PE2005001465 A PE 2005001465A PE 20060768 A1 PE20060768 A1 PE 20060768A1
- Authority
- PE
- Peru
- Prior art keywords
- pharmaceutical composition
- hydrochlorothiazide
- composition including
- telmisartane
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicinal Preparation (AREA)
Abstract
REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE 80 MG DE UN ANTAGONISTA DEL RECEPTOR DE ANGIOTENSINA II TAL COMO EL TELMISARTANO Y 25 MG DE UN DIURETICO TAL COMO HIDROCLOROTIAZIDA. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA QUE PUEDE DIVIDIRSE EN MITADES QUE COMPRENDE 160 MG DE TELMISARTANO Y 50 MG DE HIDROCLOROTIAZIDA. LA COMPOSICION PUEDE CONTENER, ADEMAS, HIDROXIDO DE SODIO, MEGLUMINA, POVIDONA, SORBITOL, ESTEARATO DE MAGNESIO, LACTOSA MONOHIDRATADA, CELULOSA MICROCRISTALINA, ALMIDON DE MAIZ, ENTRE OTROS. DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE LA HIPERTENSION, ACCIDENTES CEREBRO VASCULARES, INSUFICIENCIA CARDIACA CONGESTIVA, RESISTENCIA A LA INSULINA, ENTRE OTROS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63706204P | 2004-12-17 | 2004-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20060768A1 true PE20060768A1 (es) | 2006-09-29 |
Family
ID=35589356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2005001465A PE20060768A1 (es) | 2004-12-17 | 2005-12-15 | Composicion farmaceutica que comprende hidroclorotiazida y telmisartano |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1827424A1 (es) |
JP (1) | JP2008524136A (es) |
KR (1) | KR20070097511A (es) |
CN (1) | CN101080225A (es) |
AR (1) | AR052052A1 (es) |
AU (1) | AU2005315855A1 (es) |
BR (1) | BRPI0519656A2 (es) |
CA (1) | CA2589493A1 (es) |
EA (1) | EA200701159A1 (es) |
IL (1) | IL183944A0 (es) |
NO (1) | NO20072325L (es) |
PE (1) | PE20060768A1 (es) |
TW (1) | TW200637546A (es) |
UY (1) | UY29274A1 (es) |
WO (1) | WO2006063737A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7232828B2 (en) | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
US8637078B2 (en) | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
EP1970053A1 (en) * | 2007-03-14 | 2008-09-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pharmaceutical composition |
SI2180882T1 (sl) † | 2007-10-19 | 2013-05-31 | Otsuka Pharmaceutical Co., Ltd. | Trdni matriksni farmacevtski pripravek |
EP2203158A4 (en) | 2007-10-30 | 2012-12-26 | Reddys Lab Ltd Dr | PHARMACEUTICAL FORMULATIONS WITH TELMISARTAN AND HYDROCHLORTHIAZIDE |
CA2715350C (en) | 2008-03-19 | 2017-02-14 | Ratiopharm Gmbh | Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
PE20110551A1 (es) * | 2008-07-31 | 2011-09-02 | Takeda Pharmaceutical | Composicion farmaceutica solida que contiene un derivado de bencimidazol y un diuretico |
GB0822170D0 (en) * | 2008-12-04 | 2009-01-14 | Arrow Int Ltd | Telmisartan with diuretic formulations |
WO2010146187A2 (en) | 2009-06-19 | 2010-12-23 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of telmisartan |
EP2448576A2 (en) * | 2009-07-02 | 2012-05-09 | Mahmut Bilgic | Solubility enhancing pharmaceutical composition |
WO2011002425A2 (en) * | 2009-07-02 | 2011-01-06 | Bilgig Mahmut | Pharmaceutical composition increasing solubility and stability |
TR200906506A2 (tr) | 2009-08-24 | 2011-03-21 | Bi̇lgi̇ç Mahmut | Telmisartan içeren katı dozaj formları. |
WO2011161123A2 (en) | 2010-06-21 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Multilayer pharmaceutical tablet comprising telmisartan and a diuretic |
WO2014119767A1 (ja) * | 2013-01-31 | 2014-08-07 | 沢井製薬株式会社 | テルミサルタンとヒドロクロロチアジドとを含有する多層錠剤 |
JP6422868B2 (ja) * | 2013-07-23 | 2018-11-14 | 第一三共株式会社 | 高血圧症の予防又は治療のための医薬 |
CN106562973A (zh) * | 2016-11-06 | 2017-04-19 | 成都先先先生物科技有限公司 | 一种抗高血压药物复方制剂 |
CN107501192A (zh) * | 2017-08-15 | 2017-12-22 | 中国科学院上海药物研究所 | 替米沙坦与氢***的共晶 |
CN108653227A (zh) * | 2018-08-09 | 2018-10-16 | 湖北舒邦药业有限公司 | 一种替米沙坦氢***片及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4229085C2 (de) * | 1992-09-01 | 1996-07-11 | Boehringer Mannheim Gmbh | Längliche, teilbare Tablette |
PT1854454E (pt) * | 2002-01-16 | 2014-01-09 | Boehringer Ingelheim Pharma | Método para a preparação de telmisartan amorfo |
-
2005
- 2005-12-09 JP JP2007545905A patent/JP2008524136A/ja active Pending
- 2005-12-09 KR KR1020077016354A patent/KR20070097511A/ko not_active Application Discontinuation
- 2005-12-09 EA EA200701159A patent/EA200701159A1/ru unknown
- 2005-12-09 EP EP05814002A patent/EP1827424A1/en not_active Withdrawn
- 2005-12-09 CA CA002589493A patent/CA2589493A1/en not_active Abandoned
- 2005-12-09 AU AU2005315855A patent/AU2005315855A1/en not_active Abandoned
- 2005-12-09 CN CNA2005800434334A patent/CN101080225A/zh active Pending
- 2005-12-09 BR BRPI0519656-6A patent/BRPI0519656A2/pt not_active Application Discontinuation
- 2005-12-09 WO PCT/EP2005/013224 patent/WO2006063737A1/en active Application Filing
- 2005-12-15 PE PE2005001465A patent/PE20060768A1/es not_active Application Discontinuation
- 2005-12-16 AR ARP050105303A patent/AR052052A1/es unknown
- 2005-12-16 TW TW094144909A patent/TW200637546A/zh unknown
- 2005-12-20 UY UY29274A patent/UY29274A1/es not_active Application Discontinuation
-
2007
- 2007-05-04 NO NO20072325A patent/NO20072325L/no not_active Application Discontinuation
- 2007-06-14 IL IL183944A patent/IL183944A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200637546A (en) | 2006-11-01 |
AU2005315855A1 (en) | 2006-06-22 |
WO2006063737A1 (en) | 2006-06-22 |
EP1827424A1 (en) | 2007-09-05 |
NO20072325L (no) | 2007-07-06 |
CN101080225A (zh) | 2007-11-28 |
IL183944A0 (en) | 2007-10-31 |
AR052052A1 (es) | 2007-02-28 |
EA200701159A1 (ru) | 2007-12-28 |
KR20070097511A (ko) | 2007-10-04 |
CA2589493A1 (en) | 2006-06-22 |
BRPI0519656A2 (pt) | 2009-03-03 |
UY29274A1 (es) | 2006-07-31 |
JP2008524136A (ja) | 2008-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20060768A1 (es) | Composicion farmaceutica que comprende hidroclorotiazida y telmisartano | |
CL2008003595A1 (es) | Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central. | |
UA86831C2 (uk) | Композиція таблетки пролонгованого вивільнення, яка містить праміпексол або його фармацевтично прийнятну сіль, спосіб її виготовлення та її застосування | |
BRPI0507887A (pt) | comprimido de múltiplas camadas | |
AR087210A2 (es) | Formulacion farmaceutica de la sal sodica del telmisartan | |
WO2011014587A3 (en) | Ophthalmic pharmaceutical compositions of dp2 receptor antagonists | |
ECSP10010160A (es) | Composiciones farmaceuticas de accion doble basadas en super-estructuras de antagonista/bloqueador del receptor de angiotensina (arb) e inhibidor de endopeptidasa neutra (nep) | |
ATE380547T1 (de) | Zweischichtige pharmazeutische tablette enthaltend telmisartan und hydrochlorothiazid | |
CY1109719T1 (el) | Σκευασμα 1-[(3-υδροξυ-αδαμαντ-1-υλαμινο)-ακετυλο]-πυρρολιδινο-2-(s)-καρβονιτριλιου τροποποιημενης απελευθερωσης | |
PE20020082A1 (es) | Composicion farmaceutica que comprende un inhibidor de aldosterona-sintasa y un antagonista del receptor de angiotensina ii (at1) | |
AR040681A1 (es) | Composicion de tabletas de liberacion sostenida de pramipexol | |
CL2008001946A1 (es) | Compuestos derivados de imidazol, antagonistas de receptores ccr2, ccr3, ccr5; procedimiento de preparacion; y uso en el tratamiento de enfermedades vasculares perifericas. | |
MY145089A (en) | Pharmaceutical composition | |
EA201001312A1 (ru) | Твердая фармацевтическая композиция, содержащая непептидный антагонист рецептора ангиотензина ii и диуретик | |
MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
PE20121131A1 (es) | Composicion farmaceutica oral solida en comprimido monocapa que comprende irbesartan y besilato de amlodipina | |
AR066168A1 (es) | Formulaciones galenicas de compuestos organicos | |
UY30461A1 (es) | Composicion farmacéutica para la anticoncepcion y para reducir el riesgo de malformaciones congénitas. | |
DOP2006000280A (es) | Nuevos derivados de furopirimidina acíclicos sustituidos y su uso | |
MX2007013468A (es) | Composiciones que contienen tanaproget micronizado. | |
EP2540294A4 (en) | SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION | |
PE20120421A1 (es) | Composicion farmaceutica que comprende aleglitazar | |
PE20020617A1 (es) | Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina | |
CL2009000896A1 (es) | Compuestos derivados de 3-fenilpirazolo[5,1-b]tiazol sustituido; composicion farmaceutica; utiles en el tratamiento de la depresion, ansiedad, isquemia, apoplejia, hipertension, esquizofrenia, entre otras enfermedades. | |
UA100883C2 (ru) | Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |